Home / Recombinant human coagulation factor VIII / Moroctocog alfa (recombinant human coagulation factor VIII)
Back to Search

Moroctocog alfa (recombinant human coagulation factor VIII) – Uses, Dosage, and Brands in UAE

Brand Name: XYNTHA
Strength: 1000 IU | Form: Powder For Solution For Injection
Price in UAE: AED 4015.00
Available in UAE pharmacies

About Moroctocog alfa (recombinant human coagulation factor VIII)

Class: | Recombinant human coagulation factor VIII Use: | Treatment and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency) Adult dose: | Initial dose of 20 to 40 IU/kg body weight, with subsequent doses based on clinical response; dosing frequency may vary from every 12 to 48 hours depending on the severity of the bleeding episode and individual response Pediatric dose: | Initial dose of 20 to 40 IU/kg body weight; similar to adults, dosing fr

Drug Class

Recombinant human coagulation factor VIII

Uses & Indications

Treatment and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency)

Storage Requirements

Store at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light; after reconstitution, use within 3 hours if stored at room temperature

Manufacturer & Packaging

Manufacturer: Wyeth Farma S.A., SPAIN

Package Size

1 Vial (Powder) + 1 Pre-filled Syringe Diluent (4ml) + Kit

Price & Supplier

Price in UAE: AED 4015.00

Dosage Information

Adult Dose

Initial dose of 20 to 40 IU/kg body weight, with subsequent doses based on clinical response; dosing frequency may vary from every 12 to 48 hours depending on the severity of the bleeding episode and individual response

Pediatric Dose

Initial dose of 20 to 40 IU/kg body weight; similar to adults, dosing frequency may vary based on clinical response and severity of bleeding

Side Effects

Common side effects include headache, infusion site reactions, fever, and allergic reactions; potential for development of inhibitors (antibodies against factor VIII)

Contraindications & Precautions

Hypersensitivity to the active substance or any of the excipients; history of severe allergic reactions to factor VIII products

Important Warnings

Monitor for signs of allergic reactions; patients with hemophilia A may develop inhibitors; use caution in patients with a history of thromboembolic events; ensure proper dosing to avoid under-treatment or over-treatment of bleeding episodes

Other Brands & Strengths Available in UAE

Different brands and strengths of Moroctocog alfa (recombinant human coagulation factor VIII) available in UAE pharmacies:

XYNTHA 1000 IU Powder For Solution For Injection XYNTHA 1000 IU Powder For Solution For Injection XYNTHA 2000 IU Powder For Solution For Injection XYNTHA 2000 IU Powder For Solution For Injection XYNTHA 250 IU Powder For Solution For Injection XYNTHA 250 IU Powder For Solution For Injection XYNTHA 500 IU Powder For Solution For Injection XYNTHA 500 IU Powder For Solution For Injection XYNTHA SOLOFUSE 1000 IU Powder For Solution For Injection XYNTHA SOLOFUSE 2000 IU Powder For Solution For Injection

Related Medicines in Same Category

See also: Other Recombinant human coagulation factor VIII medicines available in UAE pharmacies

Simoctocog alfa (r-Human coagulation Factor VIII) Simoctocog alfa (r-Human coagulation Factor VIII) Simoctocog alfa (r-Human coagulation Factor VIII)

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. The information presented here is specific to medicines available in UAE pharmacies and is regularly updated to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.

View All Recombinant human coagulation factor VIII Medicines Browse All Categories